A new treatment for acute myeloid leukemia could prove beneficial for even more people

by Peter MacCallum Cancer CentreAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainNew research published inScience Advancestoday conducted by researchers at Peter MacCallu

Updated on: February 20,2024

A new treatment for acute myeloid leukemia could prove beneficial for even more people

by Peter MacCallum Cancer CentreAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainNew research published inScience Advancestoday conducted by researchers at Peter MacCallu

Updated on:February 20,2024

Leukemia treatment breakthrough for babies

by Hayley Jarvis,Brunel UniversityComparison of K562-t(7;12) transcriptional landscape with t(7;12) patient signatures. A 177-gene signature of t(7;12)-patient gene expression extrapolated from

Updated on: February 23,2024

Leukemia treatment breakthrough for babies

by Hayley Jarvis,Brunel UniversityComparison of K562-t(7;12) transcriptional landscape with t(7;12) patient signatures. A 177-gene signature of t(7;12)-patient gene expression extrapolated from

Updated on:February 23,2024

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on: August 27,2024

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on:August 27,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on: March 20,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on:March 20,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on: April 07,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on:April 07,2024

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe

Updated on: July 17,2024

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe

Updated on:July 17,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on: March 21,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on:March 21,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on: March 30,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on:March 30,2024

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on: March 14,2024

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on:March 14,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on: February 03,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on:February 03,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on: February 18,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on:February 18,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024